Health Catalyst, Inc. (NASDAQ: HCAT) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $15.00 price target on the stock, down previously from $17.00.
Health Catalyst, Inc - Common stock (HCAT)
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm
Check Earnings Report
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
HCAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HCAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HCAT alerts
High impacting Health Catalyst, Inc - Common stock news events
Weekly update
A roundup of the hottest topics
HCAT
News
- Healthcare Analytics Market Size in APAC is set to grow by USD 20.84 billion from 2024-2028, Growing integration of big data with healthcare analytics to boost the market growth, Technavio [Yahoo! Finance]Yahoo! Finance
- Health Catalyst, Inc. (NASDAQ: HCAT) had its price target lowered by analysts at Piper Sandler from $15.00 to $14.00. They now have an "overweight" rating on the stock.MarketBeat
- Health Catalyst completes acquisition of Carevive Systems [Seeking Alpha]Seeking Alpha
- Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive [Yahoo! Finance]Yahoo! Finance
- Health Catalyst Acquires Oncology-Focused Health Technology Company CarevivePR Newswire
HCAT
Earnings
- 5/9/24 - Beat
HCAT
Sec Filings
- 6/17/24 - Form 4
- 6/17/24 - Form 4
- 6/17/24 - Form 4
- HCAT's page on the SEC website